Skip to Content

Vaccines, Volume 14, Issue 1

2026 January - 109 articles

Cover Story: Killed whole-cell genome-reduced bacteria (KWC/GRB), a new, rapid, inexpensive, easily manufactured, distribution-friendly, and modular vaccine platform, enables production of vaccine candidates within three weeks. Its modular design supports rapid design–build–test cycles, facilitating the generation of modified antigens with enhanced immunogenicity. Using the platform’s features, we developed strategies to enhance a test antigen’s immunogenicity by nearly an order of magnitude  through the inclusion of immunomodulators and multimeric antigens separated by long alpha-helical linkers in the expressed immunogen. The immunogen-engineering strategies we developed may prove valuable for enhancing responses to low-immunogenicity antigens within the KWC/GRB vaccine platform and beyond, while also contributing to a broader understanding of the determinants of immunogenicity. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (109)

  • Article
  • Open Access
1,180 Views
13 Pages

22 January 2026

Background: Vibrio harveyi is a major bacterial pathogen threatening turbot aquaculture, necessitating the development of more effective vaccines. Bacterial ghosts (BGs), which are empty bacterial envelopes with preserved surface antigens, offer a pr...

(This article belongs to the Special Issue Advances in Aquatic Animal Immunology and Vaccine Development for Disease Prevention)
  • Review
  • Open Access
1,973 Views
11 Pages

22 January 2026

Annual influenza vaccination remains critical for mitigating severe illness and reducing healthcare strain, particularly among high-risk populations. Despite advancements in vaccine platforms, the comparative efficacy of novel vaccines—such as...

(This article belongs to the Special Issue The Recent Development of Influenza Vaccine: 2nd Edition)
  • Article
  • Open Access
2,301 Views
15 Pages

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain

  • Maria A. Nikiforova,
  • Vladimir A. Gushchin,
  • Denis A. Kleymenov,
  • Anastasia M. Kocherzhenko and ,
  • Evgeniia N. Bykonia,
  • Elena P. Mazunina,
  • Sofia R. Kozlova,
  • Leonid I. Russu,
  • Nadezhda A. Kuznetsova and
  • Alexander L. Gintsburg
  • + 15 authors+ 10 authors

21 January 2026

Background/Objectives: While tick-borne encephalitis virus (TBEV) is genetically relatively conserved, the significant antigenic divergence between its main circulating subtypes hinders the development of broadly effective antiviral treatments and va...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)
  • Article
  • Open Access
1,610 Views
15 Pages

Preparation and Efficacy Evaluation of Heat-Resistant Freeze-Dried Live-Attenuated Vaccine Formulation of Micropterus salmoides Rhabdovirus

  • Hongru Liang,
  • Guangwei Hu,
  • Xia Luo,
  • Qiang Lin and ,
  • Xiaozhe Fu,
  • Yinjie Niu,
  • Baofu Ma,
  • Wenwen Xiao,
  • Zhengwei Cui and
  • Ningqiu Li
  • + 5 authors+ 0 author

21 January 2026

Background/Objectives: An attenuated strain of Micropterus salmoides rhabdovirus (MSRV) 0509 with good immunogenicity has been isolated, showing potential as a candidate for live vaccine development. Methods: To improve the shelf life of attenuated s...

(This article belongs to the Section Veterinary Vaccines)
  • Review
  • Open Access
2 Citations
1,605 Views
18 Pages

21 January 2026

Global cancer incidence reached 20 million new cases across 185 countries in 2022, with approximately 10 million cancer-related deaths annually. Among adults with solid tumors and hematological malignancies, infections are a major contributor to morb...

(This article belongs to the Special Issue Challenges to Developing New Vaccines and Improving Existing Platforms)
  • Review
  • Open Access
7 Citations
3,189 Views
29 Pages

Hidden Targets in Cancer Immunotherapy: The Potential of “Dark Matter” Neoantigens

  • Francois Xavier Rwandamuriye,
  • Alec J. Redwood,
  • Jenette Creaney and
  • Bruce W. S. Robinson

21 January 2026

The development of cancer immunotherapies has transformed cancer treatment paradigms, yet durable and tumour-specific responses remain elusive for many patients. Neoantigens, immunogenic peptides arising from tumour-specific genomic alterations, have...

(This article belongs to the Special Issue Tumor Vaccines: Current Processes, Prevailing Challenges and Future Perspectives)
  • Article
  • Open Access
4 Citations
1,879 Views
17 Pages

21 January 2026

Background/Objectives: While new vaccines are in development; one strategy to increase influenza vaccine coverage is to repurpose current influenza vaccines for intranasal delivery. Methods: To address this goal; mice were vaccinated intranasally wit...

(This article belongs to the Special Issue Immunity to Influenza Viruses and Vaccines)
  • Article
  • Open Access
2,286 Views
12 Pages

Real-World Effectiveness of Seasonal Influenza Vaccines During the 2024–2025 Season: Subgroup Analyses by Virus Subtype, Time Since Vaccination, and Diagnostic Method

  • Yu Jung Choi,
  • Jungmin Lee,
  • Joon Young Song,
  • Seong-Heon Wie and ,
  • Jacob Lee,
  • Jin-Soo Lee,
  • Hye Won Jeong,
  • Joong Sik Eom,
  • Jang Wook Sohn and
  • Hee Jin Cheong
  • + 11 authors+ 6 authors

21 January 2026

Background/Objectives: Despite high vaccination coverage, influenza remains a public health concern in South Korea, particularly in older adults. Continuous evaluation of vaccine effectiveness (VE) is essential to optimize immunization strategies. Me...

(This article belongs to the Section Influenza Virus Vaccines)
  • Article
  • Open Access
1 Citations
1,831 Views
18 Pages

HPV and HIV Among Youth: Exploring the Role of Knowledge, Risk Perception, and Attitude to Vaccination in Prevention Strategies

  • Silvia Cocchio,
  • Andrea Cozza,
  • Matilde Obici,
  • Elisabetta Conte and ,
  • Claudia Cozzolino Cangiano,
  • Nicoletta Parise,
  • Patrizia Furlan and
  • Vincenzo Baldo
  • + 3 authors+ 0 author

21 January 2026

Background: Sexually transmitted infections (STIs) represent a significant public health problem due to their impact. Knowledge about them, perceptions of the risk of contracting them, and adherence to prevention strategies such as HPV vaccination ar...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
3 Citations
1,843 Views
12 Pages

Epidemiological Characteristics of Mumps Under Different Immunization Strategies in Henan Province

  • Zhanpei Xiao,
  • Mingxia Lu,
  • Yating Ma,
  • Yan Wang and ,
  • Mingyu Zhang,
  • Binghui Du,
  • Yiran Bai,
  • Yuzhu Ma and
  • Yanyang Zhang
  • + 4 authors+ 0 author

20 January 2026

Background: On 1 January 2019, a 2-dose mumps-containing vaccine (MuCV) immunization strategy was adopted in Henan Province before the national Expanded Program on Immunization (EPI). This study examines the epidemiological characteristics of mumps c...

  • Editorial
  • Open Access
573 Views
3 Pages

20 January 2026

As this Special Issue concludes, we are delighted to highlight the diversity, depth, and translational potential of the assembled contributions [...]

(This article belongs to the Special Issue Veterinary Vaccines and Host Immune Responses)
  • Article
  • Open Access
1,055 Views
11 Pages

The Role of MASP1, MASP2, and Mannose-Binding Lectin in the Immune Response to Hepatitis B Vaccination in Infants

  • Ayşe Esra Tapcı,
  • İsmail Bulut,
  • Serçin Taşar,
  • Zeynep Kallimci and ,
  • Kezban Çavdar Yetkin,
  • Meliha Sevim,
  • Oğuzhan Serin,
  • Medine Ayşin Taşar,
  • Mehmet Şenes and
  • Bülent Alioğlu
  • + 5 authors+ 0 author

20 January 2026

Background: Hepatitis B vaccination is the most effective strategy for preventing chronic hepatitis B virus (HBV) infection; however, interindividual variability in vaccine-induced antibody responses remains a significant challenge in the field. Inna...

(This article belongs to the Special Issue Pediatric Vaccinations)
  • Article
  • Open Access
1,581 Views
25 Pages

20 January 2026

Background/Objectives: Respiratory Syncytial Virus (RSV) causes severe disease in infants, the elderly, and immunocompromised individuals, with reinfections linked to poor induction of durable mucosal immunoglobulin A (IgA). We investigated the role...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
1,088 Views
16 Pages

Trusted Sources of COVID-19 Vaccine Information by County Characteristics in North Carolina

  • Bryson T. Staley,
  • Michael E. DeWitt,
  • Jennifer J. Wenner,
  • John W. Sanders and ,
  • Thomas F. Wierzba and
  • Katherine Poehling
  • + 1 author+ 0 author

20 January 2026

Background/Objectives: The COVID-19 pandemic disproportionately impacted rural areas across the United States, including rural North Carolina (NC). Consistent with national patterns, COVID-19 vaccination coverage as of December 2022 was higher for no...

(This article belongs to the Section Vaccines and Public Health)
  • Correction
  • Open Access
587 Views
1 Page

20 January 2026

There was an error in the original publication [...]

  • Article
  • Open Access
1 Citations
1,698 Views
17 Pages

Liver Safety Assessment of an Indonesian Hexavalent Vaccine Candidate Through Histopathology and ALT/AST Evaluation in Rats and Rabbits

  • Elisa D. Pratiwi,
  • Tiza W. Mawaddah,
  • Arif R. Sadjuri,
  • Dimas T. Nugroho and ,
  • Arip Hidayat,
  • Astria N. Nidom,
  • Zakiyyan I. Ayyuba,
  • Eka S. Wahyuningsih,
  • Kuncoro P. Santoso and
  • Chairul A. Nidom
  • + 10 authors+ 5 authors

19 January 2026

Background: Administering several separate childhood vaccines can reduce adherence to immunization schedules due to missed appointments and the burden of repeated injections. A hexavalent formulation targeting diphtheria, tetanus, pertussis, hepatiti...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
3 Citations
2,465 Views
24 Pages

A Pool of Ferritin Nanoparticles Delivering Six Proteins of African Swine Fever Virus Induces Robust Humoral and Cellular Immune Responses in Pigs

  • Zhanhao Lu,
  • Dailang Zhong,
  • Xin Song,
  • Jing Lan and ,
  • Yanjin Wang,
  • Rui Luo,
  • Shengmei Chen,
  • Ruojia Huang,
  • Hua-Ji Qiu and
  • Yuan Sun
  • + 7 authors+ 2 authors

19 January 2026

Background/Objectives: Inadequate characterization of protective antigens poses a significant challenge to the development of vaccines for African swine fever (ASF), particularly for antigen-dependent formulations such as subunit, mRNA, and recombina...

(This article belongs to the Special Issue Control Strategies and Vaccines for African Swine Fever—What Is to Come)
  • Article
  • Open Access
2,589 Views
18 Pages

HPV Vaccination Completion Among Men Who Have Sex with Men Using HIV Pre-Exposure Prophylaxis in Brazil: A Cross-Sectional Study

  • Alvaro Francisco Lopes de Sousa,
  • Lariane Angel Cepas,
  • Isadora Silva de Carvalho,
  • Caíque Jordan Nunes Ribeiro and ,
  • Guilherme Reis de Santana Santos,
  • Jean Carlos Soares da Silva,
  • Talia Gomes Luz,
  • Ruan Nilton Rodrigues Melo,
  • Lucas Brandão dos Santos and
  • Ana Paula Morais Fernandes
  • + 8 authors+ 3 authors

18 January 2026

Background: Men who have sex with men (MSM) using HIV pre-exposure prophylaxis (PrEP) experience a high burden of human papillomavirus (HPV) infection and related diseases, yet data on HPV vaccination among this group in Brazil remain limited. Aims:...

(This article belongs to the Special Issue Strategies to Enhance Vaccine Uptake and Immunization Among Underserved Populations/Vulnerable Groups)
  • Article
  • Open Access
1 Citations
1,930 Views
16 Pages

Cost-Effectiveness Analysis of a Bivalent Vaccine for Hand, Foot, and Mouth Disease: A Simulation-Based Study in Beijing, China

  • Mengyao Li,
  • Ying Shen,
  • Yonghong Liu,
  • Hui Yao and ,
  • Zhuowei Luo,
  • Da Huo,
  • Xiang Xu,
  • Wenhui Zhu,
  • Shuaibing Dong and
  • Xiaoli Wang
  • + 8 authors+ 3 authors

17 January 2026

Background: Hand, foot, and mouth disease (HFMD) remains a major public-health concern in China. While the monovalent EV-A71 vaccine has effectively reduced EV-A71–associated cases, it offers no protection against CV-A16. The introduction of a...

(This article belongs to the Special Issue Vaccine Efficacy and Disease Burden Evaluation)
  • Article
  • Open Access
1,611 Views
13 Pages

Heterogeneity in the Association Between Pneumococcal Vaccination and the Risk of Severe Community-Acquired Pneumonia in Elderly Inpatients: A Causal Forest Analysis

  • Yunhua Lan,
  • Ziyi Xin,
  • Zhuochen Lin,
  • Jialing Li and ,
  • Xin Xie,
  • Ying Xiong and
  • Dingmei Zhang
  • + 2 authors+ 0 author

16 January 2026

Background: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in the elderly. While pneumococcal vaccination is a core preventive measure, it remains unclear whether its association with severe CAP is uniform across all...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
1 Citations
1,470 Views
22 Pages

Extending ImmunoSpot® Assays’ Sensitivity for Detecting Rare Antigen-Specific B Cells to One in a Million—And Possibly Lower

  • Greg A. Kirchenbaum,
  • Noémi Becza,
  • Lingling Yao,
  • Alexey Y. Karulin and
  • Paul V. Lehmann

15 January 2026

Background/Objectives: Despite clonal expansion during a primary immune response, or after subsequent antigen encounters, the frequency of memory B cells (Bmem) specific for an antigen remains low, making their detection difficult. However, unlike se...

(This article belongs to the Special Issue Human Immune Responses to Infection and Vaccination)
  • Article
  • Open Access
1 Citations
1,191 Views
12 Pages

Protection Against Salmonella by Vaccination with Toxin–Antitoxin Self-Destructive Bacteria

  • Nady Gruzdev,
  • Jacob Pitcovski,
  • Chen Katz,
  • Nili Ruimi and ,
  • Dalia Eliahu,
  • Caroline Noach,
  • Ella Rosenzweig,
  • Avner Finger and
  • Ehud Shahar
  • + 4 authors+ 0 author

15 January 2026

Background: Salmonella is a major zoonotic foodborne pathogen. Conventional poultry vaccines may present limitations in terms of efficacy, safety, and practicality. Objectives: This study focuses on enhancing the immunogenicity and improving the safe...

(This article belongs to the Special Issue New Approaches to Vaccine Development and Delivery)
  • Article
  • Open Access
1 Citations
1,028 Views
19 Pages

15 January 2026

Background/objectives: RSV is a major cause of mortality in infants, and despite recent progress to prevent RSV in the very young, an RSV vaccine for this population is still highly warranted. Clinical studies in infants in the 1960s using formalin-i...

(This article belongs to the Special Issue Evaluation of Vaccine Efficacy, Safety and Immunogenicity Against Influenza, RSV and COVID-19)
  • Article
  • Open Access
1 Citations
1,138 Views
8 Pages

Family Decision to Immunize Against Respiratory Syncytial Virus and Associations with Seasonal Influenza and COVID-19 Vaccination

  • Leah D. Kaye,
  • Benjamin N. Fogel,
  • Ruth E. Gardner,
  • Brody J. Lipsett and ,
  • Katherine E. Shedlock,
  • Eric W. Schaefer,
  • Ian M. Paul and
  • Steven D. Hicks
  • + 3 authors+ 0 author

14 January 2026

Background: Nirsevimab, a monoclonal antibody for respiratory syncytial virus (RSV), reduces medically attended RSV infections. It was introduced in the 2023–24 RSV season. This study examined the association between caregiver vaccination (seas...

(This article belongs to the Special Issue Recent Progress of Vaccines for Respiratory Syncytial Virus (RSV))
  • Article
  • Open Access
2 Citations
2,255 Views
18 Pages

Exploratory Evaluation of Peptide-Based Immunization Targeting Fusion Glycoprotein-Derived Epitopes of Nipah Virus in Murine Model

  • Seo Young Moon,
  • Rochelle A. Flores,
  • Eun Bee Choi,
  • Seungyeon Kim and ,
  • Hyunjin Je,
  • Eun Young Jang,
  • Heeji Lim,
  • Yoo-Kyoung Lee,
  • In-Ohk Ouh and
  • Woo H. Kim
  • + 5 authors+ 0 author

13 January 2026

Background: Nipah virus (NiV), a zoonotic paramyxovirus with high case fatality and pandemic potential, remains without a licensed vaccine for humans to date. Although there has been progress in vaccine development, it remains limited, and peptide va...

(This article belongs to the Special Issue Novel Vaccines and Vaccine Technologies for Emerging Infections)
  • Editorial
  • Open Access
1,057 Views
6 Pages

Myriad Pathways to Universality: How Widely Sourced Data, Use of Frameworks and Innovative Analytic Methods Help Tackle Immunization Inequality

  • Devaki Nambiar,
  • Ahmad Reza Hosseinpoor,
  • Nicole Bergen,
  • M. Carolina Danovaro-Holliday and ,
  • Ibrahim Dadari and
  • Hope L. Johnson
  • + 1 author+ 0 author

13 January 2026

Great strides have been made in the area of immunization over the past several decades [...]

(This article belongs to the Special Issue Inequality in Immunization 2025)
  • Article
  • Open Access
1,255 Views
28 Pages

Efficacy of Plasmid DNA Delivery into Mice by Intradermal Injections Alone and Facilitated by Sonoporation or Electroporation

  • Daria Avdoshina,
  • Vladimir Valuev-Elliston,
  • Maria Belikova,
  • Alla Zhitkevich and ,
  • Anastasia Latanova,
  • Galina Frolova,
  • Oleg Latyshev,
  • Ilya Gordeychuk and
  • Ekaterina Bayurova
  • + 4 authors+ 0 author

12 January 2026

Background/Objectives: A key disadvantage of DNA vaccines is ineffective uptake of plasmid DNA, resulting in low immunogenicity. A way to overcome it is forced DNA delivery, which requires specialized equipment and/or reagents. Effective delivery of...

(This article belongs to the Section Nucleic Acid (DNA and mRNA) Vaccines)
  • Review
  • Open Access
2 Citations
2,773 Views
22 Pages

Plant Viral Vectors for Vaccine Development

  • Mehdi Shahgolzari,
  • Afagh Yavari,
  • Srividhya Venkataraman,
  • Mehrin Faija and
  • Kathleen Hefferon

12 January 2026

Plant viruses are useful tools for quickly and easily producing recombinant proteins in plants. Compared to systems that use genetically modified plants, viral vectors are easier to work with and can produce recombinant proteins faster and in larger...

(This article belongs to the Special Issue Strategies of Viral Vectors for Vaccine Development)
  • Article
  • Open Access
2,243 Views
19 Pages

Self-Multimerization of mRNA LNP-Derived Antigen Improves Antibody Responses

  • Cody A. Despins,
  • James Round,
  • Lisa Dreolini,
  • Tracy S. Lee and ,
  • Scott D. Brown and
  • Robert A. Holt
  • + 1 author+ 0 author

12 January 2026

Background: mRNA LNP technology is now being widely applied as a highly effective vaccine platform. Antigen multimerization is a well-established approach to enhance the antibody titers and protective efficacy of several protein subunit vaccines. How...

(This article belongs to the Special Issue Feature Papers of DNA and mRNA Vaccines)
  • Article
  • Open Access
2 Citations
2,288 Views
21 Pages

Beyond the Virological Benefits of the Herpes Zoster Vaccine in the Context of Primary Care

  • Carlo Fabris,
  • Lorena De Cecco Beolchi,
  • Lucia Casatta,
  • Stefano Celotto and ,
  • Marina Pellegrini,
  • Serafina Lovascio,
  • Katia Urli and
  • Pierluigi Toniutto
  • + 3 authors+ 0 author

11 January 2026

Background/Objectives: Recently, the Herpes Zoster (HZ) vaccination has been introduced, alongside influenza and pneumococcal vaccination, at age 65. Factors influencing adherence to this vaccination and its clinical benefits are not completely under...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
1 Citations
1,800 Views
17 Pages

11 January 2026

Background/Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the global COVID-19 pandemic, which led to hundreds of millions of human infections and more than seven million deaths worldwide. Major variants of concern, pa...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
1 Citations
1,754 Views
14 Pages

Donor Plasmid Optimization Enhances Expression of Feline Parvovirus VP2 Protein in the Baculovirus Expression Vector System

  • Ziyan Meng,
  • Zhen Sun,
  • Jing Li,
  • Wenjia Qiu and ,
  • Jiaqi Wei,
  • Ruitong Zhang,
  • Xiaoyu Ji,
  • Hongwei Zhu,
  • Jiayu Yu and
  • Xingxiao Zhang
  • + 9 authors+ 4 authors

10 January 2026

Background: Feline panleukopenia virus (FPV) causes acute and frequently fatal disease in cats, underscoring the urgent need for safe, rapidly effective, and scalable vaccines. While virus-like particle (VLP) vaccines are inherently safe and immunoge...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
1 Citations
1,606 Views
16 Pages

Maternal Immunization with VP8* mRNA Vaccine Yields Superior Passive Transfer of Rotavirus-Neutralizing Antibodies to Foals

  • Karin E. R. Borba,
  • Rebecca M. Legere,
  • Nathan M. Canaday,
  • Jill W. Skrobarczyk and ,
  • Zachary W. T. Arnold,
  • Elena Cotton-Betteridge,
  • Cristina Poveda,
  • Michael F. Criscitiello,
  • Angela I. Bordin and
  • Noah D. Cohen
  • + 7 authors+ 2 authors

9 January 2026

Background: Despite the availability of a killed whole-virus (KV) vaccine, diarrhea caused by equine rotavirus group A (ERVA) remains a significant health concern for foals in the United States. The vaccine is administered to pregnant mares, with foa...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
1 Citations
3,041 Views
12 Pages

Effectiveness of Follow-Up Mass Vaccination Campaigns Against Measles and Rubella to Mitigate Epidemics in West Africa (2024–2025): A Cross-Sectional Analysis of Surveillance and Coverage Data

  • Marcellin Mengouo Nimpa,
  • Ado Mpia Bwaka,
  • Felix Amate Elime,
  • Milse William Nzingou Mouhembe and ,
  • Adama Nanko Bagayoko,
  • Edouard Mbaya Munianji,
  • Christian Tague,
  • Joel Lamika Kalabudi and
  • Criss Koba Mjumbe
  • + 4 authors+ 0 author

9 January 2026

Background/Objectives: Despite large-scale measles and rubella (MR) vaccination campaigns in West Africa, measles outbreaks persist, raising concerns about campaign effectiveness, coverage, and underlying determinants. This study assesses the impact...

(This article belongs to the Section Epidemiology and Vaccination)
  • Article
  • Open Access
1,891 Views
17 Pages

COVID-19 Vaccination Knowledge, Attitudes, Perception, and Practices Among Frontline Healthcare Workers in Tunisia, 2024

  • Fatma Ben Youssef,
  • Aicha Hechaichi,
  • Hajer Letaief,
  • Sonia Dhaouadi and ,
  • Amenallah Zouaiti,
  • Khouloud Talmoudi,
  • Sami Fitouri,
  • Ahlem Fourati,
  • Rim Mhadhbi and
  • Nissaf Bouafif ep Ben Alaya
  • + 12 authors+ 7 authors

9 January 2026

Background/Objectives: Healthcare workers (HCW) in primary care settings play a significant role in recommending vaccines to patients. We aimed to describe COVID-19 vaccination knowledge, attitudes, perception, and practices (KAPP) of HCWs in Tunisia...

(This article belongs to the Special Issue Strategies and Innovations to Recover Post-Pandemic Losses in Routine Immunization Coverage)
  • Article
  • Open Access
2,373 Views
21 Pages

Non-Vaccine Serotype Replacement and Subdominant Persistence of Vaccine Types in Nepalese Infants Following PCV10 Introduction

  • Fleurette Mbuyakala Domai,
  • Dhruba Shrestha,
  • Raj Kumar Shrestha,
  • Monika Thimi and ,
  • Desmond Opoku Ntiamoah,
  • Yumiko Hayashi,
  • Chris Smith,
  • Yoshinao Kubo,
  • Shunmay Yeung and
  • Bhim Gopal Dhoubhadel
  • + 8 authors+ 3 authors

8 January 2026

Background: Streptococcus pneumoniae is a leading cause of child mortality in Nepal despite the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10). Vaccine effectiveness is threatened by the emergence of non-vaccine serotypes (...

(This article belongs to the Section Epidemiology and Vaccination)
  • Systematic Review
  • Open Access
2 Citations
2,577 Views
23 Pages

8 January 2026

Background: Solid organ transplant recipients (SOTRs) are highly vulnerable to severe COVID-19 infection, yet initial vaccine trials provided limited data on efficacy and safety in this immunocompromised population. Heterogeneous seroconversion rates...

(This article belongs to the Special Issue Immunization of Immunosuppressed Patients)
  • Article
  • Open Access
2,178 Views
19 Pages

Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing Antibodies

  • Valeria Caputo,
  • Martina Libera,
  • Yailin Campos Mota,
  • Kaito Nagashima and ,
  • Ana Maria Moreno Martin,
  • Claudia Maria Trombetta,
  • Francesca Dapporto,
  • Jarrod J. Mousa,
  • Emanuele Montomoli and
  • Roberta Antonia Diotti
  • + 6 authors+ 1 author

8 January 2026

Background/Objective: The influenza virus remains one of the most prevalent respiratory pathogens, posing significant global health and economic challenges. According to the World Health Organization, the seasonal influenza virus infects up to 1 bill...

(This article belongs to the Special Issue Influenza Virus Infections, Vaccines and Diagnosis)
  • Article
  • Open Access
2,492 Views
10 Pages

Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine (SKYCellflu® QIV) in Children and Adolescents: A Multicenter Test-Negative Case–Control Study in Korea

  • Yoonsun Yoon,
  • Hye Su Jeong,
  • Kyeongmin Oh,
  • Young June Choe and ,
  • Hyun Mi Kang,
  • Ji Young Park,
  • Hye Young Kim and
  • Yun-Kyung Kim
  • + 3 authors+ 0 author

8 January 2026

Background: Children and adolescents are pivotal in the transmission of influenza, and vaccination remains the most effective preventive measure. Cell-based influenza vaccines offer advantages over traditional egg-based vaccines by reducing egg-adapt...

(This article belongs to the Section Influenza Virus Vaccines)
  • Article
  • Open Access
1 Citations
1,729 Views
17 Pages

Nanoparticle Vaccines Based on the Truncated VZV gE Elicit a Robust Immune Response in Mice

  • Tianxin Shi,
  • Hai Li,
  • Jiehui Wu,
  • Hongqiao Hu and ,
  • Jie Jiang,
  • Ruichen Wang,
  • Ziyi Li,
  • Qianqian Cui,
  • Shihong Fu and
  • Songtao Xu
  • + 9 authors+ 4 authors

7 January 2026

Background: Herpes zoster (HZ), caused by the reactivation of varicella-zoster virus (VZV), primarily affects elderly populations worldwide. Although current recombinant HZ vaccines show strong immunogenicity, their high cost and potential side effec...

(This article belongs to the Special Issue Challenges to Developing New Vaccines and Improving Existing Platforms)
  • Article
  • Open Access
3 Citations
2,188 Views
24 Pages

Evaluating the Immunogenicity and Protective Efficacy of a Novel Vaccine Candidate Against Salmonella in Poultry

  • Roshen N. Neelawala,
  • Varsha Bommineni,
  • Chaitanya Gottapu,
  • Lekshmi K. Edison and ,
  • Krishni K. Gunathilaka,
  • Gary D. Butcher,
  • John F. Roberts and
  • Subhashinie Kariyawasam
  • + 3 authors+ 0 author

7 January 2026

Background: Non-typhoidal Salmonella (NTS) is a major foodborne pathogen, with poultry products, especially eggs, being the primary source of human infections. Current serovar-specific poultry vaccines effectively reduce targeted Salmonella serovars...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
1 Citations
2,094 Views
22 Pages

Alternative Childhood Vaccination Schedules in Israel: A Mixed-Methods Study on Prevalence, Patterns, and Public Health Implications

  • Efrat Sales,
  • Eliya Cohen,
  • Deena R. Zimmerman,
  • Nadav Davidovitch and ,
  • Alison McCallum and
  • Keren Dopelt
  • + 1 author+ 0 author

6 January 2026

Background/Objectives: Vaccination programs are highly effective public health interventions, yet parental hesitancy toward combination vaccines has led to growing demand for alternative vaccination schedules, defined in this study as parental reques...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 2nd Edition)
  • Article
  • Open Access
1 Citations
1,926 Views
20 Pages

Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models

  • Hajar Mohammadi Barzelighi,
  • Zahra Naderi Saffar,
  • Erfan Pakatchian,
  • Mohammad Taqavian and ,
  • Babak Javadimehr,
  • Mansooreh Safaeian,
  • Payam Abbaszadeh and
  • Hasan Jalili
  • + 3 authors+ 0 author

5 January 2026

Background: A quadrivalent HPV vaccine (BPV) has been developed to prevent diseases caused by HPV types 6, 11, 16, and 18 for the first time in Iran. The BPV is composed of the papillomavirus major capsid protein L1, which serves as the primary targe...

(This article belongs to the Section Human Papillomavirus Vaccines)
  • Review
  • Open Access
14 Citations
6,059 Views
34 Pages

The Yellow Fever Vaccine Journey: Milestones and Future Directions

  • Shriyansh Srivastava,
  • Nandani Jayaswal,
  • Pranav Gupta,
  • Sathvik Belagodu Sridhar and ,
  • Pooja Jaiswal,
  • Mohd. Tariq,
  • G. S. N. Koteswara Rao,
  • Aroop Mohanty,
  • Sanjit Sah and
  • Alfonso J. Rodriguez-Morales
  • + 9 authors+ 4 authors

5 January 2026

Yellow fever, a mosquito-borne viral hemorrhagic disease, remains a significant public health concern in endemic regions of Africa and South America. The development of the yellow fever vaccine marked a milestone in virology and immunization. In the...

(This article belongs to the Special Issue Vaccines Against Flaviviruses and Alphaviruses: Recent Advances and Future Challenges—2nd Edition)
  • Article
  • Open Access
1 Citations
1,242 Views
16 Pages

Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines

  • Alena Reguzova,
  • Melanie Müller,
  • Madeleine Fandrich,
  • Alex Dulovic and
  • Ralf Amann

4 January 2026

Background: Emerging immune-evasive viral variants threaten the efficacy of current vaccines, underscoring the need for strategies that elicit broad and durable protection. Heterologous prime–boost regimens combining distinct vaccine platforms...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Article
  • Open Access
2,082 Views
22 Pages

Influenza Vaccine Immunogenicity in Hemodialysis Patients

  • Anna-Polina Shurygina,
  • Ekaterina Romanovskaya-Romanko,
  • Vera Krivitskaya,
  • Mariia Sergeeva and ,
  • Janna Buzitskaya,
  • Kirill Vasilyev,
  • Marina Shuklina,
  • Konstantin Vishnevskii,
  • Smotrov Dmitry and
  • Marina Stukova
  • + 7 authors+ 2 authors

4 January 2026

Background: Patients with end-stage renal disease (ESRD) on hemodialysis are at increased risk for severe influenza, and underlying immune dysfunction may limit vaccine-induced protection. Methods: This observational open-label study evaluated immune...

(This article belongs to the Special Issue Evaluation of Vaccine Efficacy, Safety and Immunogenicity Against Influenza, RSV and COVID-19)
  • Article
  • Open Access
1,685 Views
19 Pages

Immunotherapy of Canine Leishmaniasis by Vaccination with Singlet Oxygen-Inactivated Leishmania infantum

  • Laura Manna,
  • Raffaele Corso,
  • Bala K. Kolli,
  • Namhee Kim and
  • Kwang Poo Chang

4 January 2026

Background: Canine leishmaniasis is notoriously difficult to manage by chemotherapy alone, necessitating the consideration of supplemental or alternative treatment. Evidence is presented to support the feasibility of immunotherapy of diseased dogs th...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Article
  • Open Access
1,300 Views
10 Pages

The Reasons to Get Vaccinated: A Cross-Sectional Study on HPV Vaccination Adherence in a Northern Italian University

  • Pier Mario Perrone,
  • Riccardo Zanzi,
  • Elia Biganzoli,
  • Fabrizio Pregliasco and
  • Silvana Castaldi

4 January 2026

Background/Objectives: Human papillomavirus (HPV) represents a major public health challenge due to its high prevalence and the complications arising from infection. The aim of the study was to investigate the reasons for adherence to the HPV vaccina...

(This article belongs to the Section Human Papillomavirus Vaccines)
  • Editorial
  • Open Access
2,205 Views
2 Pages

Vaccines in 2025: What Is New in Vaccine Advocacy?

  • Lavinia Bianco and
  • Christian Napoli

4 January 2026

The scientific literature is quite rich when it comes to vaccines and vaccination: just by looking at PubMed, using as “Vaccin* [Title/Abstract]” a search key, it is possible to obtain more than 480,000 results starting from 1799, and mor...

(This article belongs to the Special Issue Vaccine Acceptance and Uptake: Insights from Behavioural and Social Sciences)

of 3

XFacebookLinkedIn
Vaccines - ISSN 2076-393X